BONE 2 (IMAGE)
Caption
MicroCT scans of rodents show those treated with the conjugate of trastuzumab and alendronate (far right), created at Rice University and Baylor College of Medicine, fared far better than those treated with phosphate-buffered saline (PBS) or alendronate (ALN) or trastuzumab (Tras) alone 82 days after tumor implantation.
Credit
Baylor College of Medicine/Rice University
Usage Restrictions
None
License
Licensed content